Specifically, higher levels of ACP5 were likely observed in patients with severe IPF (DLCO < 40% predicted), indicating that ACP5 may be a surrogate biochemical marker for the severity of IPF. Here, ACP5 is linked to idiopathic pulmonary fibrosis.